Ampio says its study on Covid-19 patients proceeding to full open enrollment
Ampio Pharmaceuticals Inc has announced that its AP-014 Phase I inhaled Ampion clinical study in Covid-19 patients is proceeding to full open enrollment after...
NeuroRx starts Phase 2/3 study of inhaled ZYESAMI
NeuroRx, Inc. has announced initiation of a Phase 2/3 clinical trial investigating the role of inhaled ZYESAMI (aviptadil).
The trial is being done for the...
Is immediate immunity against COVID-19 possible? Grifols starts clinical trial of new treatment
Grifols has announced it will begin a clinical trial in Spain to evaluate the safety and efficacy of a new COVID-19 immunity drug based...
Drawbridge Health ties up with University of Cambridge researchers
Drawbridge Health and the Medical Research Council (MRC) Epidemiology Unit, University of Cambridge announced the use of the OneDraw Blood Collection Device for remote...
ResMed announces expansion of AirView remote monitoring for ventilation in India
ResMed has announced expansion of AirView for Ventilation, its cloud-based remote monitoring and management platform for respiratory care patients, in India.
According to the leading...
Scientists of National Institutes of Health find important pathway that coronaviruses use to exit...
Scientists at the National Institutes of Health have discovered a pathway that the coronaviruses use to exit cells.
This discovery is expected to provide vital...
Clues in human genome used by Scientists to find new inflammatory syndrome
Researchers attached to the National Institutes of Health (NIH) have found a new inflammatory disorder called vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic syndrome...
Lupus Research Awards 2023 announced
The Lupus Research Alliance (LRA) announced the recipients of the newest Lupus Innovation Award (LIA) grants.
Collectively, the seven projects led by research teams from the U.S. and Europe explore multiple...
Codagenix, Serum Institute of India start first-in-human trial of Covid-19 vaccine
Codagenix, Inc., and the Serum Institute of India Pvt. Ltd. (SIIPL) have announced that a Phase 1 clinical trial of COVI-VAC received regulatory approval...
Covid-19 investigational therapeutics to be analysed in big clinical trials
Covid-19 investigational therapeutics are to be evaluated in large clinical trials. Two controlled, randomized Phase 3 clinical trials have started evaluating investigational monoclonal antibodies...
